Open AccessDiagnostic value of DACT-2 methylation in serum of prostate cancer patients
Author(s) -
Ting Lan,
Lingyu Yin,
Haoliang Zhang,
Bing Gu,
Ping Ma,
Shibao Li,
Hongchun Li
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-20-1496
Subject(s) - medicine , methylation , receiver operating characteristic , prostate cancer , oncology , gastroenterology , cancer , gene , chemistry , biochemistry
Currently, prostate cancer (PCa) remains a hard nut to crack for the medical community. Therefore, the identification and development of novel biomarkers that can accurately diagnose disease and predict prognosis are of paramount importance. The objective of this study was to examine the clinical value of DACT-2 promoter methylation in serum of patients with PCa, to discover a potential diagnostic marker for PCa.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom